Future studies involving larger and adequately powered cohorts will be necessary to investigate the potential interactive effects between ApoE4 and NLRP3 polymorphisms on miRNA and protein expression levels in AD patients. The gene discussed is NLRP3; the disease is Alzheimer disease.